Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Rifampicin remains one of the first-line drugs used in tuberculosis therapy. This drug´s potential to induce the hepatic cytochrome P450 oxidative enzyme system increases the risk of drug-drug interactions. Thus, although the presence of comorbidities typically necessitates the use of multiple drugs, the co-administration of rifampicin and warfarin may lead to adverse drug events. | Rifampicin-warfarin interaction leading to macroscopic hematuria: A case report and review of the literature
